ACTIVE

Organon Belgium

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result2,3 M €+2,3 %over 1 year
Revenue78,5 M €+12,3 %over 1 year
Equity14,8 M €+18,7 %over 1 year
Workforce38,9 ETP-8,9 %over 1 year

Identity

Source · BCE/KBO

Organon Belgium is a Private limited company incorporated in 2020. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bruxelles. It employs on average 38,9 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0741.785.526
Incorporation
20/01/2020
Legal form
Private limited company
Registered office
Rue de la Loi 34
1040 Bruxelles · BruxellesSee on map
Contributed capital
5 381 310,00 €
Latest accounts
31/12/2025
Average workforce
38,9 ETP
Joint committees (1)
  • 200
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 7 filings

Trend over 6 financial years

20252024202320222021
Income statement
Revenue78,5 M €69,9 M €56,3 M €48,8 M €51,7 M €
EBITDA3,2 M €3,1 M €2,4 M €2 M €2 M €
Operating result3,1 M €2,8 M €2,3 M €1,9 M €1,9 M €
Net result2,3 M €2,3 M €1,9 M €1,4 M €1,4 M €
Balance sheet
Equity14,8 M €12,5 M €10,2 M €8,3 M €7 M €
Total assets25,2 M €22,9 M €17,8 M €19,2 M €17,7 M €
Cash15,2 M €13,6 M €8,2 M €8,3 M €6,2 M €
Debts10,4 M €10,4 M €7,6 M €10,9 M €10,8 M €
Other
Workforce38,9 ETP42,7 ETP41,2 ETP37,1 ETP29,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 11 ended

Active mandates

Katrien Venken

Director · since 01 juillet 2024 · until 01 avril 2025

Active
Kristof Meir

Director · since 01 juillet 2024

Active
Rooseleer Isabelle

Director · since 28 mai 2021

Active

Ended mandates

Isabel Vandenberck

Director · since 28 mai 2021 · until 01 juillet 2024

Ended
Isabel Vandenberk

Director · since 28 mai 2021

Ended
Isabel Vandenberk

Administrator - manager · since 28 mai 2021

Ended
Isabelle Rooseleer

Administrator - manager · since 28 mai 2021

Ended

Other companies at this address

Rue de la Loi 34 1040 Bruxelles
CompanyCBE no.
BOLLINGER GROHMANN INGENIERIE● Active
0736.546.536
FONDS EUROPEEN POUR LA DEMOCRATIE● Active
0501.635.104
OFFICE COMMERCIAL DE L'AMBASSADE D'ESPAGNE● Active
0850.106.812
Polyclinique Europ - Centre● Active
0417.757.224

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202120/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date24/06/202607/07/202527/06/202428/06/202323/11/202215/07/2021
General meeting24/06/202625/06/202526/06/202428/06/202329/06/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 7 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202524/06/202624/06/2026DutchPDF
Full model31/12/202425/06/202507/07/2025DutchPDF
Full model31/12/202326/06/202427/06/2024DutchPDF
Full model31/12/202228/06/202328/06/2023DutchPDF
Full modelCorrection31/12/202129/06/202223/11/2022DutchPDF
Full model31/12/202129/06/202230/06/2022DutchPDF
Full model31/12/202030/06/202115/07/2021DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 11 ended

Active mandates

Katrien Venken

Director · since 01 juillet 2024 · until 01 avril 2025

Active
Kristof Meir

Director · since 01 juillet 2024

Active
Rooseleer Isabelle

Director · since 28 mai 2021

Active

Ended mandates

Isabel Vandenberck

Director · since 28 mai 2021 · until 01 juillet 2024

Ended
Isabel Vandenberk

Director · since 28 mai 2021

Ended
Isabel Vandenberk

Administrator - manager · since 28 mai 2021

Ended
Isabelle Rooseleer

Administrator - manager · since 28 mai 2021

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates04/06/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office31/12/2024
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates25/07/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/04/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates08/03/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates11/06/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring18/01/2021
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring20/11/2020
    KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20252,3 M €↑
  2. 2024
    Annual accounts 20242,3 M €↑
  3. 2023
    Annual accounts 20231,9 M €↑
  4. 2022
    Annual accounts 20221,4 M €↓
  5. 2021
    Annual accounts 20211,4 M €↑
  6. 2020
    Annual accounts 2020193 k €
  7. 20/01/2020
    IncorporationPrivate limited company